GreenHouse Holdings, Inc. (GRHU)
A survey conducted by Institute for Building Efficiency in 2010 showed the importance of energy efficiency for decision makers is on the rise, with 71 percent of respondents admitting that they are now paying more attention to energy efficiency than they did a year ago. Although motivations are different from region to region, the common denominator influencing change is cost savings. The second most important factor for energy efficiency was lowering greenhouse gas emissions, except for in North America, where boosting public image and taking advantage of government incentives ranked higher in importance.
GreenHouse Holdings, Inc is a leading provider of energy efficiency and sustainable facilities solutions. The company designs, engineers and installs disparate products and technologies that enable its clients to reduce their energy costs and carbon footprint. Its target markets for energy efficiency solutions include government, military as well as commercial, residential and industrial markets. In addition, the company develops designs and constructs rapidly deployable, sustainable facilities primarily for use in disaster relief and security in austere regions.
GreenHouse Holdings, Inc recently executed a letter of intent with Hinds Community College to construct and manage a $2.9 million Anti-Terrorism Tactical Training Center in Jackson, Mississippi that would provide local law enforcement personnel with a state-of-the-art training and sustainable firing range facility and which would serve as a best practices model for such facilities in small cities and towns across the United States. The project is subject to the execution of a definitive agreement.
For more information about GRHU, please visit: www.greenhouseintl.com
Cleantech Transit, Inc. (CLNO)
One of the main benefits of biomass fuel over fossil fuel can be best understood in terms of greenhouse gasses. While both biomass fuels and fossil fuels release about the same amount of carbon dioxide into the atmosphere when burned, there is a distinct difference in the effect they each have on the atmosphere. Burning fossil fuel releases carbon dioxide that was captured during photosynthesis literally millions of years ago. As it is burned, carbon dioxide is released as a new greenhouse gas, a ‘new’ carbon dioxide. Biomass fuel, on the other hand, releases carbon dioxide that was recently captured during photosynthesis and it tends to equal itself out. Nothing ‘new’ is being sent into the atmosphere, thus greatly reducing the greenhouse gas effect on the ozone layer Biomass has generated energy from the time man created the first fire, and wood is still the largest bioenergy resource available today.
Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net). This project could generate returns well benefit the Company’s manufacturing clients worldwide.
Cleantech Transit Inc recently reported that it signed an agreement with Phoenix Energy (www.phoenixenergy.net), a manufacturer and distributor of biomass-generated power plants. Cleantech has an option to acquire a 25% interest in a fully constructed, 500-Kilowatt Biomass Project in California, which is Cleantech’s first step towards developing an asset base in the environmentally friendly biomass arena. With a fully operational biomass facility coming online in the near term, they plan on moving forward with implementation of their strategic plans.
For more information about Cleantech Transit, Inc. visit its website www.cleantechtransitinc.com
J. Alexander’s Corp. (Nasdaq:JAX) reported operating results for the fourth quarter and year ended January 2, 2011. The 2010 fiscal year included 52 weeks compared to 53 weeks in the prior year while the fourth quarter of 2010 included 13 weeks compared to 14 weeks in the final quarter a year earlier. A summary of the fourth quarter of 2010 compared to the fourth quarter of 2009 follows: Net sales decreased 0.5% to $38,793,000 from $38,996,000 because of the additional week in the 2009 quarter. Net sales for the quarter increased by $2,398,000, or 6.6%, when compared to the comparable 13 weeks ended January 3, 2010. Average weekly same store sales per restaurant increased by 7.3% on a quarter-to-quarter basis, and by 6.6% when compared to the comparable 13 weeks ended January 3, 2010. Income before income taxes was $732,000. This compares to a loss before income taxes of $4,644,000 in the 2009 quarter which included non-cash asset impairment charges of $3,889,000. The loss for the fourth quarter of 2009 before income taxes and asset impairment charges was $755,000.
J. Alexander’s Corporation operates full-service casual dining restaurants in the United States. Its restaurants offer American menu featuring prime rib of beef; hardwood-grilled steaks, seafood, and chicken; pasta; salads and soups; assorted sandwiches, appetizers, and desserts; and a full-service bar.
Dehaier Medical Systems Limited (Nasdaq:DHRM) announced that it has signed a distribution agreement with Shanghai Haopu Medical Instruments Co. Ltd. to become a regional distributor of eVent Medical’s inspiration ventilator in the Chinese market. Under the agreement, Dehaier will sell eVent’s inspiration ventilators to hospitals, clinics and medical facilities through its direct sales force and nationwide network of over 2,000 dealers and distributors.
Dehaier Medical Systems Limited, through its subsidiaries, designs, develops, and markets respiratory and oxygen homecare products, and other medical devices in the People’s Republic of China. The company also distributes products designed and manufactured by other companies.
Osiris Therapeutics, Inc. (Nasdaq:OSIR) announced its results for the fourth quarter and full year ended December 31, 2010. Recent and Full Year Highlights: Completed enrollment in a 220-patient Phase 2 trial for patients experiencing their first heart attack. Submitted Prochymal New Drug Submission (NDS) to the Biologics and Genetic Therapies Directorate of Health Canada.Received Orphan Drug designation from Swissmedic, the Swiss Agency for Therapeutic Products, and the Therapeutic Goods Administration, Australia’s regulatory agency for medical drugs and devices, for Prochymal as a treatment for GvHD, making the drug eligible for expedited review.Granted Priority Review for Prochymal by Health Canada. Announced a positive interim analysis of the first 207 patients in a clinical trial evaluating Prochymal for treatment-resistant Crohn’s disease and continued patient enrollment.Granted Orphan Drug designation from the Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes.
Osiris Therapeutics, Inc., a stem cell therapeutic company, focuses on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas in the United States and internationally.
__
No comments:
Post a Comment